Company Filing History:
1 out of 1 
1 out of 66 
Years Active: 2025
Title: Maren Köhne: Innovator in Antibody Development
Introduction
Maren Köhne is a prominent inventor based in Mainz, Germany. She has made significant contributions to the field of biotechnology, particularly in the development of antibodies for therapeutic applications. Her innovative work focuses on enhancing the efficacy of cancer treatments through advanced antibody technology.
Latest Patents
Maren Köhne holds a patent for "Antibodies capable of binding to OX40, variants thereof and uses thereof." This invention relates to antibodies that can bind to human OX40, featuring a modified Fc region with mutations that enhance Fc-Fc interactions while reducing Fc effector functions. The patent also includes pharmaceutical compositions that utilize these antibodies for therapeutic and diagnostic procedures, especially in cancer therapy. She has 1 patent to her name.
Career Highlights
Throughout her career, Maren has worked with notable companies in the biotechnology sector, including Genmab A/S and BioNTech SE. Her experience in these organizations has allowed her to contribute to groundbreaking research and development in antibody therapies.
Collaborations
Maren has collaborated with esteemed colleagues such as Kristel Kemper and Maarten Van Der Kroef. These partnerships have further enriched her research and innovation in the field.
Conclusion
Maren Köhne's work in antibody development represents a significant advancement in cancer therapy. Her innovative patents and collaborations highlight her commitment to improving therapeutic options for patients.